Human Immunodeficiency Virus Type 1 Neutralization Measured by Flow Cytometric Quantitation of Single-Round Infection of Primary Human T Cells

There is currently intensive research on the design of novel human immunodeficiency virus type 1 (HIV-1) vaccine immunogens that can elicit potent neutralizing antibodies. A prerequisite for comparing and optimizing these strategies is the ability to precisely measure neutralizing antibody responses...

ver descrição completa

Detalhes bibliográficos

Publicado no:	J Virol
Principais autores:	Mascola, John R., Louder, Mark K., Winter, Christine, Prabhakara, Ranjani, De Rosa, Stephen C., Douek, Daniel C., Hill, Brenna J., Gabuzda, Dana, Roederer, Mario
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 2002
Assuntos:	Vaccines and Antiviral Agents
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC136170/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11967298/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/JVI.76.10.4810-4821.2002
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!